A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). | NCT00441558

Overview

Key facts that identify this study and show where it stands today.

Description

What the study is about and why it is being run, in the researchers' own words.

Conditions

The medical conditions and diseases this study investigates.

Interventions

The treatments and procedures being evaluated in this study.

Participation

Who can join this study and the criteria used to decide.

Design

How the study is designed and how its participant groups are organized.

Contacts

The people to reach with questions about this study or how to join it.

Locations

Where the study is run and whether each site is currently recruiting.

Collaborators

The organizations and people involved in this study.

Similar Studies

Other registered studies that closely resemble this one.

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD). | NCT00441558 | Trialant

511.84.01079 Boehringer Ingelheim Investigational Site

Birmingham, Alabama, United States

511.84.01193 Boehringer Ingelheim Investigational Site

Birmingham, Alabama, United States

511.84.01188 Boehringer Ingelheim Investigational Site

Huntsville, Alabama, United States

511.84.01110 Boehringer Ingelheim Investigational Site

Mobile, Alabama, United States

511.84.01142 Boehringer Ingelheim Investigational Site

Mobile, Alabama, United States

511.84.01157 Boehringer Ingelheim Investigational Site

Mobile, Alabama, United States

511.84.01162 Boehringer Ingelheim Investigational Site

Little Rock, Alaska, United States

511.84.01070 Boehringer Ingelheim Investigational Site

Phoenix, Arizona, United States

511.84.01191 Boehringer Ingelheim Investigational Site

Phoenix, Arizona, United States

511.84.01115 Boehringer Ingelheim Investigational Site

Tucson, Arizona, United States

511.84.01013 Boehringer Ingelheim Investigational Site

Jonesboro, Arkansas, United States

511.84.01087 Boehringer Ingelheim Investigational Site

Berkeley, California, United States

511.84.01077 Boehringer Ingelheim Investigational Site

Encinitas, California, United States

511.84.01074 Boehringer Ingelheim Investigational Site

Fair Oaks, California, United States

511.84.01104 Boehringer Ingelheim Investigational Site

Irvine, California, United States

511.84.01037 Boehringer Ingelheim Investigational Site

La Jolla, California, United States

511.84.01056 Boehringer Ingelheim Investigational Site

Sacramento, California, United States

511.84.01195 Boehringer Ingelheim Investigational Site

Sacramento, California, United States

511.84.01043 Boehringer Ingelheim Investigational Site

San Diego, California, United States

511.84.01047 Boehringer Ingelheim Investigational Site

San Diego, California, United States

511.84.01096 Boehringer Ingelheim Investigational Site

San Diego, California, United States

511.84.01040 Boehringer Ingelheim Investigational Site

Stanford, California, United States

511.84.01048 Boehringer Ingelheim Investigational Site

Tarzana, California, United States

511.84.01017 Boehringer Ingelheim Investigational Site

Torrance, California, United States

511.84.01173 Boehringer Ingelheim Investigational Site

Vista, California, United States

511.84.01029 Boehringer Ingelheim Investigational Site

Walnut Creek, California, United States

511.84.01137 Boehringer Ingelheim Investigational Site

Westlake Village, California, United States

511.84.01090 Boehringer Ingelheim Investigational Site

Aurora, Colorado, United States

511.84.01164 Boehringer Ingelheim Investigational Site

Denver, Colorado, United States

511.84.01184 Boehringer Ingelheim Investigational Site

Denver, Colorado, United States

511.84.01004 Boehringer Ingelheim Investigational Site

Englewood, Colorado, United States

511.84.01006 Boehringer Ingelheim Investigational Site

Wheat Ridge, Colorado, United States

511.84.01138 Boehringer Ingelheim Investigational Site

Farmington, Connecticut, United States

511.84.01044 Boehringer Ingelheim Investigational Site

Groton, Connecticut, United States

511.84.01016 Boehringer Ingelheim Investigational Site

Hartford, Connecticut, United States

511.84.01108 Boehringer Ingelheim Investigational Site

New Britain, Connecticut, United States

511.84.01168 Boehringer Ingelheim Investigational Site

New London, Connecticut, United States

511.84.01166 Boehringer Ingelheim Investigational Site

Newark, Delaware, United States

511.84.01160 Boehringer Ingelheim Investigational Site

Washington D.C., District of Columbia, United States

511.84.01065 Boehringer Ingelheim Investigational Site

Aventura, Florida, United States

511.84.01005 Boehringer Ingelheim Investigational Site

Boynton Beach, Florida, United States

511.84.01146 Boehringer Ingelheim Investigational Site

Clearwater, Florida, United States

511.84.01144 Boehringer Ingelheim Investigational Site

Coral Gables, Florida, United States

511.84.01169 Boehringer Ingelheim Investigational Site

Daytona Beach, Florida, United States

511.84.01085 Boehringer Ingelheim Investigational Site

Fort Lauderdale, Florida, United States

511.84.01194 Boehringer Ingelheim Investigational Site

Fort Meyers, Florida, United States

511.84.01002 Boehringer Ingelheim Investigational Site

Gainesville, Florida, United States

511.84.01069 Boehringer Ingelheim Investigational Site

Gainsville, Florida, United States

511.84.01007 Boehringer Ingelheim Investigational Site

Hudson, Florida, United States

511.84.01055 Boehringer Ingelheim Investigational Site

Miami, Florida, United States

511.84.01064 Boehringer Ingelheim Investigational Site

Miami, Florida, United States

511.84.01182 Boehringer Ingelheim Investigational Site

New Port Richey, Florida, United States

511.84.01167 Boehringer Ingelheim Investigational Site

Ocala, Florida, United States

511.84.01111 Boehringer Ingelheim Investigational Site

Orlando, Florida, United States

511.84.01118 Boehringer Ingelheim Investigational Site

Orlando, Florida, United States

511.84.01135 Boehringer Ingelheim Investigational Site

Pembroke Pines, Florida, United States

511.84.01032 Boehringer Ingelheim Investigational Site

Plantation, Florida, United States

511.84.01175 Boehringer Ingelheim Investigational Site

Sarasota, Florida, United States

511.84.01053 Boehringer Ingelheim Investigational Site

St. Petersburg, Florida, United States

511.84.01132 Boehringer Ingelheim Investigational Site

St. Petersburg, Florida, United States

511.84.01117 Boehringer Ingelheim Investigational Site

Stuart, Florida, United States

511.84.01159 Boehringer Ingelheim Investigational Site

Tampa, Florida, United States

511.84.01170 Boehringer Ingelheim Investigational Site

Tampa, Florida, United States

511.84.01183 Boehringer Ingelheim Investigational Site

Tampa, Florida, United States

511.84.01003 Boehringer Ingelheim Investigational Site

West Palm Beach, Florida, United States

511.84.01022 Boehringer Ingelheim Investigational Site

West Palm Beach, Florida, United States

511.84.01024 Boehringer Ingelheim Investigational Site

Atlanta, Georgia, United States

511.84.01061 Boehringer Ingelheim Investigational Site

Atlanta, Georgia, United States

511.84.01205 Boehringer Ingelheim Investigational Site

Atlanta, Georgia, United States

511.84.01176 Boehringer Ingelheim Investigational Site

Marietta, Georgia, United States

511.84.01139 Boehringer Ingelheim Investigational Site

Roswell, Georgia, United States

511.84.01023 Boehringer Ingelheim Investigational Site

Sandy Springs, Georgia, United States

511.84.01179 Boehringer Ingelheim Investigational Site

Champaign, Illinois, United States

511.84.01113 Boehringer Ingelheim Investigational Site

Chicago, Illinois, United States

511.84.01165 Boehringer Ingelheim Investigational Site

Chicago, Illinois, United States

511.84.01172 Boehringer Ingelheim Investigational Site

Chicago, Illinois, United States

511.84.01143 Boehringer Ingelheim Investigational Site

Evansville, Indiana, United States

511.84.01092 Boehringer Ingelheim Investigational Site

Indianapolis, Indiana, United States

511.84.01202 Boehringer Ingelheim Investigational Site

Wichita, Kansas, United States

511.84.01049 Boehringer Ingelheim Investigational Site

Lexington, Kentucky, United States

511.84.01025 Boehringer Ingelheim Investigational Site

Baton Rouge, Louisiana, United States

511.84.01171 Boehringer Ingelheim Investigational Site

Lafayette, Louisiana, United States

511.84.01192 Boehringer Ingelheim Investigational Site

New Orleans, Louisiana, United States

511.84.01130 Boehringer Ingelheim Investigational Site

New Orlean, Louisiana, United States

511.84.01001 Boehringer Ingelheim Investigational Site

Baltimore, Maryland, United States

511.84.01120 Boehringer Ingelheim Investigational Site

Brighton, Massachusetts, United States

511.84.01030 Boehringer Ingelheim Investigational Site

Haverhill, Massachusetts, United States

511.84.01127 Boehringer Ingelheim Investigational Site

Ann Arbor, Michigan, United States

511.84.01081 Boehringer Ingelheim Investigational Site

Bingham Farms, Michigan, United States

511.84.01147 Boehringer Ingelheim Investigational Site

Bingham Farms, Michigan, United States

511.84.01041 Boehringer Ingelheim Investigational Site

Detroit, Michigan, United States

511.84.01131 Boehringer Ingelheim Investigational Site

Chaska, Minnesota, United States

511.84.01128 Boehringer Ingelheim Investigational Site

Chesterfield, Missouri, United States

511.84.01051 Boehringer Ingelheim Investigational Site

Kansas City, Missouri, United States

511.84.01034 Boehringer Ingelheim Investigational Site

St Louis, Missouri, United States

511.84.01042 Boehringer Ingelheim Investigational Site

Billings, Montana, United States

511.84.01156 Boehringer Ingelheim Investigational Site

Omaha, Nebraska, United States

511.84.01148 Boehringer Ingelheim Investigational Site

Las Vegas, Nevada, United States

511.84.01206 Boehringer Ingelheim Investigational Site

Moorestown, New Jersey, United States

511.84.01010 Boehringer Ingelheim Investigational Site

New Brunswick, New Jersey, United States

511.84.01045 Boehringer Ingelheim Investigational Site

Albequerque, New Mexico, United States

511.84.01050 Boehringer Ingelheim Investigational Site

Endwell, New York, United States

511.84.01066 Boehringer Ingelheim Investigational Site

Poughkeepsie, New York, United States

511.84.01187 Boehringer Ingelheim Investigational Site

Purchase, New York, United States

511.84.01038 Boehringer Ingelheim Investigational Site

Rochester, New York, United States

511.84.01059 Boehringer Ingelheim Investigational Site

The Bronx, New York, United States

511.84.01178 Boehringer Ingelheim Investigational Site

Chapel Hill, North Carolina, United States

511.84.01121 Boehringer Ingelheim Investigational Site

New Bern, North Carolina, United States

511.84.01119 Boehringer Ingelheim Investigational Site

Raleigh, North Carolina, United States

511.84.01072 Boehringer Ingelheim Investigational Site

Winston-Salem, North Carolina, United States

511.84.01106 Boehringer Ingelheim Investigational Site

Beachwood, Ohio, United States

511.84.01008 Boehringer Ingelheim Investigational Site